Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)
Public ClinicalTrials.gov record NCT05520099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method
Study identification
- NCT ID
- NCT05520099
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 416 participants
Conditions and interventions
Conditions
- Immunotherapy
- Cancer
- Bladder Cancer
- Urothelial Carcinoma Bladder
- Kidney Cancer
- Clear Cell Renal Cell Cancer (ccRCC)
- Colorectal Cancer
- MSI-H Colorectal Cancer
- DMMR Colorectal Cancer
- Head and Neck Cancer (H&N)
- Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
- Liver Cancer
- Hepatocellular Carcinoma (HCC)
- Lung Cancer (NSCLC)
- NSCLC (Non-small Cell Lung Cancer)
- Skin Cancer
- Cutaneous Melanoma
- Endometrial Cancer
- Solid Tumor Cancer
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 26, 2023 (Actual)
- Primary completion
- Jan 2027 (Estimated)
- Completion
- Jan 2027 (Estimated)
- Last update posted
- Jun 29, 2026
2023 – 2027
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CARTI Cancer Center | Little Rock | Arkansas | 72205 | — |
| Salinas Valley Memorial Healthcare System | Salinas | California | 93901 | — |
| AdventHealth Orlando | Orlando | Florida | 32803 | — |
| Memorial Health System | Pembroke Pines | Florida | 33026 | — |
| Cleveland Clinic Florida | Stuart | Florida | 34994 | — |
| University of South Florida (Tampa General Hospital) | Tampa | Florida | 33606 | — |
| University of Louisville James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Meritus Center for Clinical Research | Hagerstown | Maryland | 21742 | — |
| John Theurer Cancer Center | Hackensack | New Jersey | 07601 | — |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14203 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| University of Wisconsin | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05520099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 29, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05520099 live on ClinicalTrials.gov.